Pages that link to "Q37472002"
Jump to navigation
Jump to search
The following pages link to In vivo delivery of a microRNA-regulated transgene induces antigen-specific regulatory T cells and promotes immunologic tolerance (Q37472002):
Displaying 50 items.
- MicroRNA-regulated viral vectors for gene therapy (Q26745822) (← links)
- Gene therapy for hemophilia (Q28081911) (← links)
- Liver-targeted gene therapy: Approaches and challenges (Q28085748) (← links)
- Pigmy MicroRNA: surveillance cops in Therapies kingdom (Q28818470) (← links)
- Current progress and challenges in HIV gene therapy (Q29393523) (← links)
- Endothelial transcription factor KLF2 negatively regulates liver regeneration via induction of activin A (Q33569270) (← links)
- Prolonged prophylactic protection from botulism with a single adenovirus treatment promoting serum expression of a VHH-based antitoxin protein (Q34110625) (← links)
- Exploiting microRNA regulation for genetic engineering (Q34302499) (← links)
- Inhibitors - cellular aspects and novel approaches for tolerance (Q34380850) (← links)
- Ex Vivo Expanded Autologous Polyclonal Regulatory T Cells Suppress Inhibitor Formation in Hemophilia. (Q34424570) (← links)
- Eradication of neutralizing antibodies to factor VIII in canine hemophilia A after liver gene therapy (Q34541550) (← links)
- Effect of miR-142-3p on the M2 macrophage and therapeutic efficacy against murine glioblastoma (Q34736639) (← links)
- Development of Gene Transfer for Induction of Antigen-specific Tolerance (Q34794525) (← links)
- Portal vein delivery of viral vectors for gene therapy for hemophilia (Q34795284) (← links)
- Hepatocyte-targeted expression by integrase-defective lentiviral vectors induces antigen-specific tolerance in mice with low genotoxic risk (Q35038004) (← links)
- miRNA-mediated Silencing in Hepatocytes Can Increase Adaptive Immune Responses to Adenovirus Vector-delivered Transgenic Antigens (Q35144457) (← links)
- Gene therapy for the nervous system: challenges and new strategies (Q35340196) (← links)
- Effects of APC De-targeting and GAr modification on the duration of luciferase expression from plasmid DNA delivered to skeletal muscle (Q35646675) (← links)
- Gene therapy for haemophilia: prospects and challenges to prevent or reverse inhibitor formation (Q35670173) (← links)
- RILES, a novel method for temporal analysis of the in vivo regulation of miRNA expression. (Q37271181) (← links)
- Liver transplant tolerance and its application to the clinic: can we exploit the high dose effect? (Q37331781) (← links)
- Pervasive supply of therapeutic lysosomal enzymes in the CNS of normal and Krabbe-affected non-human primates by intracerebral lentiviral gene therapy (Q37453863) (← links)
- Integration-deficient lentiviral vectors: a slow coming of age. (Q37506025) (← links)
- Non-coding RNAs as therapeutic targets in hepatocellular cancer. (Q37562406) (← links)
- Small RNA regulators of T cell-mediated autoimmunity (Q37731387) (← links)
- Gene therapy strategies for hemophilia: benefits versus risks (Q37789715) (← links)
- Antigen-specific immunotherapy of autoimmune and allergic diseases (Q37790023) (← links)
- Emerging applications of lentiviral vectors in dendritic cell-based immunotherapy (Q37793233) (← links)
- Physiological and tissue-specific vectors for treatment of inherited diseases (Q37801839) (← links)
- MicroRNA therapeutics. (Q37869804) (← links)
- Stem cell MicroRNAs in senescence and immortalization: novel players in cancer therapy (Q37906461) (← links)
- Endogenous migration modulators as parent compounds for the development of novel cardiovascular and anti-inflammatory drugs (Q37950457) (← links)
- Gene therapy for rheumatoid arthritis: current status and future prospects (Q37952287) (← links)
- Manipulating Immune Tolerance with Micro-RNA Regulated Gene Therapy. (Q37965158) (← links)
- Immune responses in liver-directed lentiviral gene therapy. (Q38077611) (← links)
- Progress toward inducing immunologic tolerance to factor VIII. (Q38090391) (← links)
- MicroRNAs in kidney diseases: new promising biomarkers for diagnosis and monitoring (Q38115932) (← links)
- Lentiviral vectors for cancer immunotherapy and clinical applications (Q38147100) (← links)
- Synthetic biology: applying biological circuits beyond novel therapies (Q38679815) (← links)
- MicroRNA-142 is a multifaceted regulator in organogenesis, homeostasis, and disease. (Q38791157) (← links)
- Gene therapy for immune tolerance induction in hemophilia with inhibitors (Q38803022) (← links)
- RNA-based gene circuits for cell regulation (Q39007260) (← links)
- Liver gene therapy by lentiviral vectors reverses anti-factor IX pre-existing immunity in haemophilic mice (Q39084223) (← links)
- Liver-Directed Adeno-Associated Viral Gene Therapy for Hemophilia (Q39553052) (← links)
- Repeated AAV-mediated gene transfer by serotype switching enables long-lasting therapeutic levels of hUgt1a1 enzyme in a mouse model of Crigler-Najjar Syndrome Type I. (Q40084021) (← links)
- Antigen-presenting cell-targeted lentiviral vectors do not support the development of productive T-cell effector responses: implications for in vivo targeted vaccine delivery. (Q40187007) (← links)
- MicroRNA Expression Shows Inflammatory Dysregulation and Tumor-Like Proliferative Responses in Joints of Patients With Postinfectious Lyme Arthritis. (Q40376412) (← links)
- Dynamics of antigen presentation to transgene product-specific CD4 T cells and of Treg induction upon hepatic AAV gene transfer. (Q40417058) (← links)
- In Vivo Gene Delivery to Lymph Node Stromal Cells Leads to Transgene-specific CD8 T Cell Anergy in Mice. (Q40562689) (← links)
- Hyperactive piggyBac transposons for sustained and robust liver-targeted gene therapy (Q40782473) (← links)